These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2922105)

  • 1. Stimulation of cholinergic receptor mediated secretion from the bovine adrenal medulla by neuropeptide Y.
    Hexum TD; Russett LR
    Neuropeptides; 1989 Jan; 13(1):35-41. PubMed ID: 2922105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y release from the adrenal medulla after cholinergic receptor stimulation.
    Hexum TD; Majane EA; Russett LR; Yang HY
    J Pharmacol Exp Ther; 1987 Dec; 243(3):927-30. PubMed ID: 2891838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells.
    Higuchi H; Costa E; Yang HY
    J Pharmacol Exp Ther; 1988 Feb; 244(2):468-74. PubMed ID: 3346832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
    Nörenberg W; Bek M; Limberger N; Takeda K; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):337-47. PubMed ID: 7543184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor modulation of release of [Met5]enkephalin immunoreactive material and catecholamines from the bovine adrenal gland.
    Barron BA; Hexum TD
    Br J Pharmacol; 1986 Dec; 89(4):713-8. PubMed ID: 3814906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland.
    Lim DY; Kim YS; Miwa S
    Auton Neurosci; 2004 Jan; 110(1):27-35. PubMed ID: 14766322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process.
    Zheng J; Zhang P; Hexum TD
    Mol Pharmacol; 1997 Dec; 52(6):1027-33. PubMed ID: 9415712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
    Mahapatra NR; Mahata M; Mahata SK; O'Connor DT
    J Hypertens; 2006 May; 24(5):895-904. PubMed ID: 16612252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture.
    Wilson SP; Chang KJ; Viveros OH
    J Neurosci; 1982 Aug; 2(8):1150-6. PubMed ID: 7108586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anabasine on catecholamine secretion from the perfused rat adrenal medulla.
    Hong SP; Jeong MG; Lim DY
    J Cardiol; 2007 Dec; 50(6):351-62. PubMed ID: 18186309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y inhibition of nicotinic receptor-mediated chromaffin cell secretion.
    Hexum TD; Zheng J; Zhu J
    J Pharmacol Exp Ther; 1994 Oct; 271(1):61-6. PubMed ID: 7965758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors and receptor modulation in cultured chromaffin cells.
    Livett BG; Boksa P
    Can J Physiol Pharmacol; 1984 Apr; 62(4):467-76. PubMed ID: 6203633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors.
    Bernet F; Bernard J; Laborie C; Montel V; Maubert E; Dupouy JP
    Neurosci Lett; 1994 Jan; 166(1):109-12. PubMed ID: 8190350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine release from bovine adrenal medullary cells in culture.
    Boksa P
    J Auton Nerv Syst; 1990 Apr; 30(1):63-74. PubMed ID: 1693390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of enkephalin, proenkephalin mRNA, and neuropeptide Y in immunologically denervated rat adrenal glands: evidence for divergent peptide regulation.
    Brimijoin S; Dagerlind A; Rao R; McKinzie S; Hammond P
    J Neurochem; 1995 Mar; 64(3):1281-7. PubMed ID: 7861161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells.
    Livett BG; Dean DM; Whelan LG; Udenfriend S; Rossier J
    Nature; 1981 Jan; 289(5795):317-9. PubMed ID: 7453829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arecoline inhibits catecholamine release from perfused rat adrenal gland.
    Lim DY; Kim IS
    Acta Pharmacol Sin; 2006 Jan; 27(1):71-9. PubMed ID: 16364213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible muscarinic regulation of catecholamine secretion mediated by cyclic GMP in isolated bovine adrenal chromaffin cells.
    Derome G; Tseng R; Mercier P; Lemaire I; Lemaire S
    Biochem Pharmacol; 1981 Apr; 30(8):855-60. PubMed ID: 6264926
    [No Abstract]   [Full Text] [Related]  

  • 20. Actions of neuropeptide Y on the rat adrenal cortex.
    Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
    Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.